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Abstract
Background: We use data from rural Nepal and South India to compare the prevalence of small-for-gestational-age (SGA)
and neonatal mortality risk associated with SGA using different birth-weight-for-gestation reference populations.
Methods:We identified 46 reference populations in low-, middle-, and high-income countries, of which 26 met the inclusion
criteria of being commonly cited and having numeric 10th percentile cut points published. Those reference populations
were then applied to populations from two community-based studies to determine SGA prevalence and its relative risk of
neonatal mortality.
Results: The prevalence of SGA ranged from 10.5% to 72.5% in Nepal, and 12.0% to 78.4% in India, depending on the
reference population. Females had higher rates of SGA than males using reference populations that were not sex specific.
SGA prevalence was lowest when using reference populations from low-income countries. Infants who were both preterm
and SGA had much higher mortality risk than those who were term and appropriate-for-gestational-age. Risk ratios for those
who are both preterm and SGA ranged from 7.34–17.98 in Nepal and 5.29–11.98 in India, depending on the reference
population.
Conclusions: These results demonstrate the value of a common birth-weight-for-gestation reference population that will
facilitate comparisons of SGA prevalence and mortality risk across research studies.
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Introduction
Low birth weight (LBW) has long been recognized as an
important risk factor for infant mortality, indirectly accounting for
60–80% of the 3.1 million neonatal deaths [1,2]. LBW can occur
due to prematurity or intrauterine growth restriction (IUGR), or
both of these conditions. IUGR is defined as insufficient fetal
growth and can be due to many factors including poor maternal
nutrition, maternal infections, congenital defects, smoking, and
placental conditions [3]. Small-for-gestational-age (SGA), which is
commonly used as a measurable proxy for IUGR, is defined as
birth weight below the 10th percentile of a reference distribution
of weights specific to gestational ages, with some references
providing sex-specific distributions. It was recently estimated that
32.5 million infants in low- and middle-income countries were
born SGA, 19 million of whom were not LBW [4]. 53 percent
(16.8 million) of these SGA infants were born in South Asia [4]. In
low-income countries, a larger percent of LBW is due to IUGR
than preterm [5–8]. SGA can arise from a genetic predisposition
to small size or could be due to factors such as low maternal
height, malnutrition, and/or infection during pregnancy. The
genetic and constitutional contributions to SGA are generally felt
to be small relative to these other factors, particularly in low- and
middle-income contexts [9].
There are many different birth-weight-for-gestation reference
populations, some of which have been used extensively to calculate
the prevalence of SGA in the literature. In order to compare the
prevalence of SGA across different studies, we wished to better
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understand what impact the choice of a reference population
would have on SGA prevalence, and whether this choice would
impact the estimate of mortality risk associated with being born
SGA. To address this question, we conducted a literature review to
identify all birth-weight-for-gestation reference populations that
have been cited frequently. We then applied the 10th percentile cut
offs of each reference population to two community-based
populations in rural southern Nepal and Tamil Nadu, India,
and estimated the prevalence of SGA and its association with
neonatal mortality using gestational age, birth weight, and
mortality data.
Methods
Identification of reference populations
We identified an initial group of commonly used birth-weight-
for-gestation reference population standards, solicited from experts
(the Child Health Epidemiology Reference Group (CHERG)
investigators) [10–16]. Through a snowball approach, we exam-
ined all reference populations cited in these papers, and examined
the bibliographies for additional references. After four rounds,
most of the references in each of these papers were recurrent.
While this approach is likely biased towards the older English-
language literature, we did identify several references in other
languages (German, Dutch, French, Italian). We do not expect the
potential bias to influence our findings significantly. The primary
purpose in identifying different reference populations was to
examine the extent to which the choice influenced the prevalence
of SGA and the associated mortality risks. We categorized the
reference populations by region: North America, South America,
Europe, Asia, and Africa. If available, we recorded the years of
data collection, setting or data source, number of live births, range
of gestational ages included in the reference populations, method
of gestational age assessment, socioeconomic status, maternal
characteristics, and race or ethnicity of the population. Other key
relevant characteristics included whether the growth curves were
sex-specific, and whether stillbirths, multiple births, obstetric
complications, or infants with congenital malformation were
excluded. We also excluded reference populations where growth
curves but not the actual 10th percentile cutoffs were provided
since we would have had to interpolate the 10th percentile cut
points imprecisely in these cases. We used Web of Science
(Thompson Scientific, Inc.) and Google Scholar to identify the
number of times the paper was cited. Only those cited more than
ten times in either Web of Science or Google Scholar were used in
the analysis, with the understanding that the publication may not
necessarily have been cited as a reference population (Table S1 in
File S1). However, because the original publications did specifi-
cally describe reference populations, we felt it likely that these were
cited because they were reference populations.
Datasets
We used data from two population-based randomized trials of
neonatal interventions to calculate the prevalence of SGA using
the reference populations described above. The Nepal Newborn
Washing Study (NCT00109616) enrolled all infants born alive in
30 Village Development Committees of Sarlahi District in rural
southern Nepal (at low altitude along the Indian border with
Bihar) from September 2002 through January 2006 [17]. The trial
tested the impact of a neonatal full body wipe with chlorhexidine
or placebo at birth on neonatal mortality. The Vitamin A Study In
Newborns (NCT00114868) enrolled pregnant women from two
blocks of rural Tamil Nadu from June 1998 through March 2001
and randomized neonates to placebo or vitamin A supplementa-
tion within 48 hours of birth [18]. In both trials, study workers
who were local village women identified pregnancies at around 4–
5 months gestation, enrolled and interviewed the pregnant
women, and followed them for pregnancy outcomes. Since most
deliveries occurred at home, the village-based worker notified a
high school graduate field worker when the birth occurred. The
latter worker then went to the home to weigh the newborn with a
digital infant scale, accurate to 2 g (Seca Digital Baby Scale Model
727, Columbia, Maryland). For deliveries that occurred in
facilities, study workers waited until the mother returned home
to weigh the infant. Facility birth weights were not collected or
used in this analysis. In Nepal, gestational age was calculated by
taking the mean of two estimates using the date of last menstrual
period (LMP) by maternal recall, one obtained in mid-pregnancy
and one at the birth of the live born infant. In India, gestational
Table 1. Characteristics of Mothers and Infants in the Population-based Trials in Nepal and India.
Characteristic Nepal [17]a India [18]b
Number live births 23,662 12,936
N (%) weighed within 72 hours 20,219 (85.4) 8,908 (68.9)
N (%) singletons with gestational age recorded and weighed within 72 hours 19,966 (84.4) 8,794 (68.0)
Median age at weighing (hrs) 16.5 22.5
Mean (SD) birth weight (g) 2,696 (422) 2,651 (399)
N (%) low birth weight (,2500 g) 6,441 (32.3) 4,944 (56.2)
Mean (SD) gestational age (wks) 39.3 (2.4) 39.5 (2.8)
N (%) preterm (,37 weeks) 3,463 (17.4) 1,170 (13.3)
Number of neonatal deaths (#28 days) 325 159
Neonatal mortality per 1000 live births 16.3 18.1
% Maternal literacy 25.2 45.7
% Nulliparous 25.2 30.6
% Delivering in facility 8.0 56.1
aMissing Nepal of N = 19,966: gestational age 12, maternal literacy 10.
bMissing India of N= 8,794: gestational age 1.
doi:10.1371/journal.pone.0092074.t001
SGA Reference Population
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age was based on date of LMP by maternal recall at the time of
pregnancy identification (around mid-pregnancy). Local event
calendars were used to improve recall of dates. Gestational age was
calculated in completed weeks rather than rounding to the nearest
week.
The Nepali and Indian populations were similar with respect to
many characteristics (Table 1). Facility deliveries were more
common in South India (56% versus 8%), and maternal literacy
was higher (46% versus 25%). The proportion of all live births
weighed within 72 hours was higher in Nepal (84% versus 68%),
perhaps reflecting more home births, and those weighed within
72 hours were weighed earlier in Nepal (median 16.5 hours) than
in India (median 22.5 hours). Since birth weight was measured by
study workers, those born in facilities were generally reached for a
post-delivery visit and weighed only after the mother and infant
returned home from the facility. This delayed the weighing of the
infant relative to a home delivery. The prevalence of LBW was
similar in both populations but prematurity was higher in Nepal
(17% versus 13%). The overall neonatal mortality in each
population was similar (around 30 per 1000 live births), but the
mortality among those who survived long enough to be weighed
was significantly lower in both studies, reflecting higher mortality
risk among those not weighed. Infants who died before they were
weighed were more likely to be preterm and have died soon after
delivery. In Nepal, 6.9% of infants did not have a weight that
could be used in this analysis (4.0% were weighed after 72 hours).
In India, 23.7% of weights could not be used (17.1% were weighed
after 72 hours). Gestational age was available on over 99% in both
data sets. Further details of the studies are published elsewhere
[17,18].
Data analysis
The overall and sex-specific prevalence of SGA in the Nepali
and Indian trial populations was calculated by taking the number
of infants whose weights fell below the 10th percentile of each
reference population for a specific gestational age. The range of
Table 2. Prevalence of Small-for-Gestational Age (SGA) in Southern Nepal using Reference Populations from Five Regions [17]a.
Reference Region SGA Definition All N=19,966b Male N=10,237 Female N=9,727
% SGA (n) % SGA (n) % SGA (n)
North America Alexander [12] 1 52.3 (11, 392) 52.4 (5, 869) 52.1 (5,523)
Oken [50] 1 62.8 (12,530) 62.8 (6,426) 62.8 (6,104)
Williams [11] 1 58.6 (11,699) 59.2 (6,057) 58.0 (5,642)
Lubchenco [16] 1 35.7 (7,124) 35.2 (3,601) 36.2 (3,523)
Babson [13] c, 1 57.9 (11,544) 53.0 (5,421) 63.0 (6,123)
Ott [29] 1 71.9 (14,353) 68.7 (7,031) 75.3 (7,322)
Brenner [22] c, 1 45.6 (9,102) 40.5 (4,143) 51.0 (4,959)
Gruenwald [38] c, 1 44.5 (8,882) 39.3 (4,026) 50.0 (4,856)
Freeman (Caucasian) [24] 1 46.6 (9,302) 38.4 (3,933) 55.2 (5,369)
Freeman (Af. Am) [24] 1 28.0 (5,586) 26.7 (2,727) 29.4 (2,859)
Zhang [36] 1 62.5 (12,475) 62.8 (6,421) 62.3 (6,054)
Kramer [10] 1 68.6 (13,694) 68.3 (6,990) 69.0 (6,704)
Usher [33]c. 1 58.4 (11,648) 53.6 (5,484) 63.4 (6,164)
Europe Mamelle [25] 1 55.5 (11,066) 56.6 (5,789) 54.3 (5,277)
Skjaerven [31] 1 72.5 (14,470) 72.9 (7,461) 72.1 (7,009)
Kloosterman [40] 1 58.7 (11,712) 57.7 (5,906) 59.7 (5,806)
Parazzini [30] 1 59.1 (11,800) 59.4 (6,076) 58.8 (5,724)
Thomson [32] 1 56.6 (11,283) 57.9 (5,924) 55.1 (5,359)
Milner [26] 1 49.4 (9,855) 49.5 (5,063) 49.3 (4,792)
South America Gonzalez [37]c, 2 61.2 (12,209) 56.4 (5,770) 66.2 (6,439)
Asia Bhatia [20] 3 12.1 (2,417) 9.9 (1,008) 14.5 (1,409)
Woo [35] 2 50.1 (10,005) 44.9 (4,599) 55.6 (5,406)
Cheng (Chinese) [23] 2 41.4 (8,263) 36.4 (3,726) 46.7 (4,537)
Cheng (Malay) [23] 2 27.1 (5,407) 22.9 (2,340) 31.6 (3,067)
Cheng (Indian) [23] 2 14.4 (2,882) 12.0 (1,231) 17.0 (1,651)
Nishida [28] 1 49.6 (9,905) 44.5 (4,556) 55.0 (5,349)
Hong [39] 2 56.5 (11,275) 55.9 (5,720) 57.1 (5,555)
Africa Boersma [21] 3 10.5 (2,098) 8.6 (878) 12.6 (1,220)
Verhoeff [34] 3 34.7 (6,918) 3,481 (34.0) 35.4 (3,437)
1High Income, 2Middle Income, 3Low Income.
aFor singleton live births weighed within 72 hours of birth.
bMissing of N= 19,966: gestational age 12, sex 2.
cReference data are not sex-specific.
doi:10.1371/journal.pone.0092074.t002
SGA Reference Population
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gestational ages for which weight cutoffs was available varied
widely by reference population (Table S1 in File S1). If the
gestational age in the Nepali or Indian data fell outside the range
for a particular reference population, the 10th percentile weight cut
point of the closest gestational age in the reference population was
used. For example, if the reference population provided 10th
percentile cut points through 41 weeks gestation, that cutoff was
used for a neonate with gestational age of 42 weeks or above. If
sex-specific percentiles were available, the total prevalence of SGA
was calculated using the sex-specific reference distributions.
To examine the association between SGA, preterm, and
neonatal mortality (deaths within 28 days per 1000 singleton live
births, weighed within 72 hours and with gestational age
estimates), risk ratios (RR) and 95% confidence intervals were
calculated for term-SGA, preterm-SGA, and preterm-appropriate-
for-gestational-age (AGA), all with term-AGA as the reference.
AGA is defined as birth weight being above the 10th percentile of
the reference population at a specific gestational age. Forest plots
of these RRs and confidence intervals were used to display the
range of these estimates across the different reference populations.
We also conducted the above analyses using Mikolajczyk et al. ’s
global reference, which produces birth weight percentiles adapt-
able to each local population from gestational ages 24 to 41 and is
not sex-specific [19]. This distribution differs from those reported
above, in that it attempts to identify the true 10th percentile cut-off
of the population of interest. This global reference calls for an
input of mean birth weight at 40 weeks gestation in the population
of interest to produce a distribution; we used 2775 g for Nepal and
2640 g for India.
Results
A total of 46 reference populations were identified. Ten were
excluded from analysis because they did not provide the 10th
percentile birth weights, or provided only growth curves. Another
Table 3. Prevalence of Small-for-Gestational Age (SGA) in South India using Reference Populations from Five Regions [18]a.
Reference Region SGA Definition All N=8,794
b Male N=4,504 Female N=4,290
% SGA (n) % SGA (n) % SGA (n)
North America Alexander [12] 1 61.5 (5,859) 61.8 (3,011) 61.2 (2,848)
Oken [50] 1 70.0 (6,153) 70.0 (3,148) 70.1 (3,005)
Williams [11] 1 64.9 (5,706) 65.8 (2,965) 63.9 (2,741)
Lubchenco [16] 1 40.8 (3,587) 40.6 (1,829) 40.9 (1,758)
Babson [13] c, 1 64.8 (5,694) 60.1 (2,705) 69.7 (2,989)
Ott [29] 1 77.7 (6,831) 74.3 (3,346) 81.2 (3,485)
Brenner [22] c, 1 51.9 (4,559) 46.7 (2,103) 57.3 (2,456)
Gruenwald [38] c, 1 51.8 (4,553) 46.7 (2,104) 57.1 (2,449)
Freeman (Caucasian) [24] 1 53.8 (4,734) 45.1 (2,030) 63.0 (2,704)
Freeman (Af. Am) [24] 1 33.0 (2,896) 32.2 (1,448) 33.8 (1,448)
Zhang [36] 1 70.0 (6,156) 70.6 (3,177) 69.4 (2,979)
Kramer [10] 1 75.0 (6,595) 75.2 (3,386) 74.8 (3,209)
Usher [33] c, 1 66.1 (5,815) 61.4 (2,763) 71.1 (3,052)
Europe Mamelle [25] 1 62.9 (5,527) 63.8 (2,873) 61.9 (2,654)
Skjaerven [31] 1 78.4 (6,891) 78.8 (3,547) 78.0 (3,344)
Kloosterman [40] 1 66.3 (5,827) 65.7 (2,956) 66.9 (2,871)
Parazzini [30] 1 66.8 (5,781) 66.6 (3,001) 64.8 (2,780)
Thomson [32] 1 63.1 (5,550) 64.7 (2,911) 61.5 (2,639)
Milner [26] 1 56.9 (5,001) 57.2 (2,577) 56.5 (2,424)
South America Gonzalez [37] c, 2 68.1 (5,990) 63.7 (2,868) 72.8 (3,122)
Asia Bhatia [20] 3 13.5 (1,191) 11.7 (525) 15.5 (666)
Woo [35] 2 56.8 (4,996) 51.5 (2,318) 62.4 (2,678)
Cheng (Chinese) [23] 2 46.8 (4,113) 41.9 (1,886) 51.9 (2,227)
Cheng (Malay) [23] 2 30.8 (2,706) 26.7 (1,204) 35.0 (1,502)
Cheng (Indian) [23] 2 15.3 (1,341) 13.1 (589) 17.5 (752)
Nishida [28] 1 56.5 (4,965) 51.5 (2,321) 61.6 (2,644)
Hong [39] 2 63.0 (5,543) 62.8 (2,828) 63.3 (2,715)
Africa Boersma [21] 3 12.0 (1,056) 10.1 (454) 14.0 (602)
Verhoeff [34] 3 39.4 (3,465) 40.0 (1,799) 38.8 (1,666)
1High Income, 2Middle Income, 3Low Income.
aFor singleton live births weighed within 72 hours of birth.
bMissing of N= 8,794: gestational age 1.
cReference data are not sex-specific.
doi:10.1371/journal.pone.0092074.t003
SGA Reference Population
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ten were excluded, as they were cited less than ten times, leaving a
total of 26 reference populations [10–13,16,20–40] (Table S1 in
File S1). The gestational age for which these reference populations
provided weights ranged from 20–48 weeks. Most reference
populations were large; ten studies presented sample sizes of above
100,000, of which seven were above one million. Two studies had
sample sizes of less than 2000. North America and Europe were
disproportionately represented, with the fewest reference popula-
tions from Africa. Most estimated gestational age from date of
LMP, although some used ultrasound. All data used to develop the
reference populations were from facility-based deliveries. A wide
range of inclusion criteria was used. Some included only
singletons, others included only live births or those without
congenital malformations, and a wide range of maternal
characteristics were represented by the different reference
populations. Based on the number of times these papers were
cited, with older references more likely to be cited than newer
ones, some emerged more frequently [10–12,16,22,27,32,33,38].
Those from low-income countries and those not published in
English were least cited. Five of the references did not provide sex-
specific birth-weight-for-gestation curves.
The prevalence of SGA ranged from 10.5% to 72.5% in Nepal,
and 12.0% to 78.4% in India, depending on the reference
population used to define SGA (Tables 2 and 3). In general, SGA
was somewhat higher in India than Nepal. The prevalence of SGA
was comparable for males and females except when using reference
populations that did not have sex-specific birth-weight-for-gestation
curves. In general, females had higher rates of SGA than males
using those reference populations. The reference populations from
North America and Europe tended to produce higher estimates of
SGA relative to those from low-income countries.
The RR of neonatal mortality among SGA and/or preterm
infants also varied by reference population (Tables S2 and S3 in
File S1, Figures 1, 2, and 3 for Nepal, and Figures S1, S2, and S3
in File S1 for India). In general, the RRs were highest for reference
populations where the prevalence of SGA was lowest. This is
because when SGA prevalence is low, very few infants are
categorized as SGA, and therefore their mortality risk is high
compared with the majority categorized as AGA, resulting in
higher RRs. Compared with infants who were term-AGA, term-
SGA infants had a significantly higher risk of mortality. Those who
were preterm–AGA had a similar increased mortality risk.
However, infants who were both preterm and SGA had much
higher mortality risk than those who were neither SGA nor
preterm. These RRs for preterm-SGA babies ranged from 7.34–
17.98 in Nepal and 5.29–11.98 in India, depending on the
reference population selected.
The same methodology was used to calculate prevalence and
RR as above (i.e. using the 24 week weight cut-off for babies with
,24 week gestation and using the 41 week weight cut-off for
babies with $42 week gestation) with Mikolajczyk et al. ’s global
reference distribution. This produced a prevalence of 14.5% (male
Figure 1. Risk ratios for Term-Small-for-Gestational-Age, Neonatal Mortality: Southern Nepal (reference: Term-Appropriate-for-
Gestational-Age).
doi:10.1371/journal.pone.0092074.g001
SGA Reference Population
PLOS ONE | www.plosone.org 5 March 2014 | Volume 9 | Issue 3 | e92074
12.0%, female 17.1%) (fourth lowest, relative to the other
reference distributions) for Nepal and 11.0% (male 8.8%, female
13.3%) (lowest) for India. The prevalences were similar when
limiting the data to those within the gestational age range that has
specific birth-weight cut-offs available (24–41 weeks gestation). In
both cases, the term-SGA and preterm-SGA RRs were among the
three highest when compared to the other reference distributions,
while the preterm-AGA RRs were around the median value
(Table S4 in File S1).
Discussion
A large variety of reference populations have been used to
define SGA, making it difficult to pool estimates of SGA
prevalence and its mortality consequences using the published
literature. The prevalence of SGA and its association with
neonatal mortality can vary significantly depending on the choice
of reference population. Similar variation has been seen for
associations between SGA and developmental outcomes [41].
Reference populations from low-income countries generally
produced lower prevalence estimates but higher RRs for neonatal
mortality than those from Europe and North America. The much
higher prevalence of SGA when using high- versus low-income
country reference standards may be attributed to high-income
countries producing heavier babies, thereby creating a much
higher weight cutoff for SGA than low-income country references.
If the birth weight distributions in our Nepal and India datasets
were the same as the reference population, the prevalence of SGA
should be 10%; these are likely to be the highest risk infants in the
distribution. This was approximately what was seen when using
Mikolajczyk et al. ’s global reference distribution [19], which seeks
to create a distribution of birth-weight-for-gestation in the local
population. This distribution, which produced prevalences close to
10% for both Nepal and India studies, reported RRs for term- and
preterm-SGA that were among the highest compared to other
reference distributions.
Some populations (those representing all births in a country
over a certain time period) are intended to provide an optimal
growth population by considering those below the 10th percentile
as exhibiting poor growth. The use of a local reference population
may also document progress over time as well as tracking
morbidity and mortality risk. Mikolajczyk et al’s global reference
distribution attempts to identify the lowest 10% within each
population. The reference distribution that adapts to the local
distribution may successfully identify babies at highest risk in that
particular population, but is merely descriptive. It fails to
acknowledge that a large percent of the population beyond the
lowest 10% also have increased risk of mortality or morbidities
when compared to an ideally nourished reference, and does not
comment on how the fetus should be growing.
Goldenberg et al examined the issue of variation in reference
populations by comparing the weights that defined the 10th
Figure 2. Risk ratios for Preterm-Appropriate-for-Gestational-Age, Neonatal Mortality: Southern Nepal (reference: Term-
Appropriate-for-Gestational-Age).
doi:10.1371/journal.pone.0092074.g002
SGA Reference Population
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percentile cut-off across 13 different reference populations from
high-income countries [42]. They found that weights varied across
the reference populations from ,160 g to 820 g depending on
weeks of gestation, with the greatest variation at 42 weeks. The
reference populations varied by socioeconomic status, the inclu-
sion of multiple births, the proportion of infants who were
primiparous, and other factors that could influence the weight cut-
offs. However, the authors attribute the most variation in weight
cut-offs to the method of gestational age estimation rather than to
these other factors. Gardosi et al. have advocated customized
birth-weight-for-gestation charts that include maternal weight at
first antenatal visit, height, ethnicity, and parity [14]. They showed
that the addition of these covariates to the gestational age and sex
of the infant reduced misclassification of both small- and large-for-
gestational-age (above the 90th percentile in birth weight of a
reference population at a specific gestational age) in a population
of 4179 women in the United Kingdom. Similar findings were
obtained from Australia [43]. While such customized growth
charts are valuable for individual diagnosis and clinical use, they
are less practical for estimating the prevalence of SGA in
populations, especially in low-income settings where certain
maternal characteristics may not be collected. In particular, a
common reference population, regardless of whether it represents
optimal growth, is valuable for comparison of prevalence of SGA
and mortality risk across different populations.
Our use of two large, population-based data sets from two
different areas of South Asia provided similar results. Hence it is
likely these results are generalizable throughout South Asia. By
comparing SGA prevalence generated from different reference
populations within the same data set, we removed the variability
associated with study differences, which would normally be present
when comparing SGA prevalence in the published literature.
One limitation of this analysis was the use of dates of LMP by
the two studies to estimate gestational age. LMP estimates tend to
shift the gestational age distribution to the right [44,45] and may
be associated with substantial misclassification of preterm birth
compared to ultrasound-based dating [46]. This misclassification
may differentially impact the SGA prevalence; in general, the
tendency would be to increase SGA prevalence and decrease
relative mortality risk compared with ultrasound. Although most
of the reference populations used LMP dates, there is variation in
the methods used to determine gestational age (some ultrasound or
best obstetric estimate) and LMP dates may be more accurate in
certain settings than others (i.e., where literacy is higher). Such
variations in gestational age estimation across reference popula-
tions likely introduced additional variation in our findings.
In both of these studies, birth weight was measured with
reasonable accuracy because they were research studies. Data
collectors who were study employees were trained to follow a
standard protocol using accurate scales that were calibrated
regularly throughout the study. There was likely some inter-
observer variability, but we believe this to be a minor source of
misclassification. Table S1 in File S1 provides some information
on the way in which variables were collected across reference
Figure 3. Risk ratios for Preterm-Small-for-Gestational-Age, Neonatal Mortality: Southern Nepal (reference: Term-Appropriate-for-
Gestational-Age).
doi:10.1371/journal.pone.0092074.g003
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populations, but quality of birth weight measures could have been
quite different and these could have added to the variation in
prevalence across reference populations.
Another limitation is the range of gestational ages for which
weight cut-offs were provided. For the gestational ages lower or
higher than the bounds provided by the reference distribution, we
used the 10th percentile cut-off of the closest gestational age. By
doing so, we may be overestimating SGA prevalence in the highest
gestational ages while underestimating SGA prevalence in the
lower gestational ages.
It should be noted that our estimates of SGA prevalence and
neonatal mortality risk are biased by the exclusion of infants who
were missing birth weight or who were weighed beyond 72 hours
after delivery. Exclusion of infants who died before being weighed
will tend to reduce the prevalence of preterm and SGA since these
infants likely died because they had one or both these conditions.
However, exclusion of infants weighed after 72 hours of age would
likely bias the prevalence of preterm and SGA in the opposite
direction, since they would be less likely to be preterm and/or
SGA if they survived to 72 hours or beyond. Neither of these
biases should impact the estimates of variation by reference
population since the comparisons use the same cohort of infants.
Finally, live and stillbirths could have been misclassified in both
the trials and reference populations, perhaps more so in these two
studies and in low- than high-income reference populations. This
misclassification could have altered the estimates of RR but would
not alter the comparison of RR across reference populations
within each of the trials.
Conclusion
These results demonstrate the importance of reaching agree-
ment on the appropriate reference population that should be used
in future analyses where the primary purpose is to compare SGA
prevalence across populations and to estimate global and regional
SGA attributable burden. Local fetal growth references may still
be useful when considering growth of individual infants in resource
limited settings. As has been done with child growth standards
[47], The INTERGROWTH-21st Study has collected fetal and
neonatal growth measures from healthy women in eight countries,
using ultrasound to determine gestational age [48]. A similar
activity within the U.S. context is the recently completed NICHD
Fetal Growth Study following low risk pregnancies at twelve sites.
Whether these combined data will ultimately represent ideal fetal
growth curves is not known, but they will produce one common
reference population against which SGA prevalence and health
risks can be assessed. Prior literature will need to be re-evaluated
against these new standards, as was done for child growth [49].
These data demonstrate the importance of a common reference
population and emphasize the value of the INTERGROWTH-
21st Study to be completed in 2014.
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